Skip to main content
OpenTrials

Clinical trial condition

DNA Virus Infections

Explore clinical trials studying DNA Virus Infections. Study availability and eligibility vary by location and protocol.

3,913 public trials 504 recruiting studies
Refine in advanced search Browse all conditions

DNA Virus Infections trial results

Completed

Freeze-Dried MVA-BN® Lot Consistency Smallpox Trial

NCT03699124

Conditions
DNA Virus Infections, Infections, Poxviridae Infections, +2 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Optimal Research, LLC (Synexus) Melbourne, Florida, United States
  • Optimal Research, LLC (Synexus) Peoria, Illinois, United States
  • University of Iowa Iowa City, Iowa, United States
View Trial Details
Completed

Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL)

NCT02669017

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Burkitt's Lymphoma, +39 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Completed

Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma

NCT00052936

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +27 more
Locations
  • Haematologisch Onkologische Praxis Aachen, Germany
  • Klinikum St. Marien Amberg, Germany
  • Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie Ansbach, Germany
  • II. Medizinische Klinik Aschaffenburg, Germany
View all 174 locations
View Trial Details
Completed

Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma

NCT00290667

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +17 more
Locations
  • University Hospital Brno Brno, Czechia
  • Charles University Hospital Prague, Czechia
  • Hopital Debrousse Lyon, France
  • Haematologisch Onkologische Praxis Aachen, Germany
View all 338 locations
View Trial Details
Completed

Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma

NCT00053768

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +22 more
Locations
  • Haematologisch Onkologische Praxis Aachen, Germany
  • Klinikum St. Marien Amberg, Germany
  • Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie Ansbach, Germany
  • Specialist Practice for Oncology Aschaffenburg, Germany
View all 175 locations
View Trial Details
Completed

Consistency, Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults ≥ 50 Years of Age

NCT02075515

Conditions
DNA Virus Infections, Herpes Zoster, Herpes Zoster Vaccine, +4 more
Locations
  • GSK Investigational Site Mesa, Arizona, United States
  • GSK Investigational Site Wichita, Kansas, United States
  • GSK Investigational Site Milford, Massachusetts, United States
  • GSK Investigational Site Ghent, Belgium
View Trial Details
Completed

Study to Evaluate Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A When Co-administered With Pneumovax 23™ in Adults Aged 50 Years and Older

NCT02045836

Conditions
DNA Virus Infections, Herpes Zoster, Herpes Zoster Vaccine, +4 more
Locations
  • GSK Investigational Site Golden, Colorado, United States
  • GSK Investigational Site Wichita, Kansas, United States
  • GSK Investigational Site Columbia, Maryland, United States
  • GSK Investigational Site Coquitlam, British Columbia, Canada
View Trial Details
Completed

Maribavir for Prevention of CMV After Stem Cell Transplants

NCT00223925

Conditions
Cytomegalovirus Infection, Cytomegalovirus Infections, DNA Virus Infections, +3 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Loyola University Maywood, Illinois, United States
  • Tufts-New England Medical Center Boston, Massachusetts, United States
View all 13 locations
View Trial Details

Related conditions